Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma

NCT06044506 is registered in ClinicalTrials.gov with Dr Cipto Mangunkusumo General Hospital as lead sponsor.

NCT NCT06044506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06044506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma
Lead sponsor
Dr Cipto Mangunkusumo General Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
August 29, 2022
Completion date
December 31, 2026
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma